We serve Chemical Name:3-(2-Ethoxyphenyl)-1,1-dimethylure CAS:344333-59-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-(2-Ethoxyphenyl)-1,1-dimethylure
CAS.NO:344333-59-1
Synonyms:3-(2-Ethoxyphenyl)-1,1-dimethylure
Molecular Formula:C11H16N2O2
Molecular Weight:208.25700
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:45.06000
Exact Mass:208.12100
LogP:2.19240
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-(2-Ethoxyphenyl)-1,1-dimethylure chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-(2-Ethoxyphenyl)-1,1-dimethylure physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(2-Ethoxyphenyl)-1,1-dimethylure Use and application,3-(2-Ethoxyphenyl)-1,1-dimethylure technical grade,usp/ep/jp grade.
Related News: The Plexxikon patents are for compounds that reduce cancer cell growth by blocking V600E mutated BRAF. Patents were filed as early as 2005. 6-Amino-5-(5-trifluoromethyl-pyridin-2-ylsulfanyl)-benzofuran-3-one manufacturers The Plexxikon patents are for compounds that reduce cancer cell growth by blocking V600E mutated BRAF. Patents were filed as early as 2005. 3-((4,5-dimethylthiazol-2-yl)amino)-1-(4-hydroxypiperidin-1-yl)-2-(o-tolyl)propan-1-one suppliers “From the new company, we’ll be able to provide customers with invaluable access to high-quality sterile fill and finish capacity, which is in huge demand globally,” Recipharm CEO Marc Funk said in a release. 2-((1R,3R)-3-(2-(methoxymethoxy)ethyl)-2,2-dimethylcyclopropyl)pentan-3-one vendor & factory Flexibility in a CDMO is the key to ensure speed of tech-transfer which is a true litmus test for CDMOs which can help a company chose between competing analytical strategies, manufacturing technology and knowledge for improving productivity. ,Johnson & Johnson’s COVID-19 vaccine presents greater benefits than it does safety risks, especially amid the quickly spreading Delta variant, a key CDC expert panel decided. However, the panel said that a ruling over the need for a booster added to all COVID shots will have to start with the FDA.
